Loading...
PD1/PD-L1 Expression in Blastic Plasmacytoid Dendritic Cell Neoplasm
Patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN) have poor outcomes despite intensive chemotherapy, underscoring the need for novel therapeutic approaches. The expression status of PD1/PD-L1 in BPDCN remains unknown. We evaluated PD1/PD-L1 by immunohistochemistry and RNAseq express...
Na minha lista:
| Udgivet i: | Cancers (Basel) |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
MDPI
2019
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6562447/ https://ncbi.nlm.nih.gov/pubmed/31109153 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers11050695 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|